Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Siddhant Bhoir

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
International Journal of Molecular Sciences|July 14, 2023
Targeting Prostate Cancer, the 'Tousled Way'Siddhant Bhoir, Arrigo De Benedetti
Cancers|January 11, 2025
Beyond the Horizon: Rethinking Prostate Cancer Treatment Through Innovation and Alternative StrategiesSiddhant Bhoir, Arrigo De Benedetti
Scientific Reports|March 21, 2018
High yield bacterial expression, purification and characterisation of bioactive Human Tousled-like Kinase 1B involved in cancerSiddhant Bhoir, Althaf Shaik, Vijay Thiruvenkatam, et al.
Advanced Biology|May 3, 2023
The Role of Opioid Receptors in CancerSiddhant Bhoir, Megan Uhelski, Juan Jose Guerra-Londono, et al.
Biomedicines|November 25, 2023
Exploiting TLK1 and Cisplatin Synergy for Synthetic Lethality in Androgen-Insensitive Prostate CancerSiddhant Bhoir, Oluwatobi Ogundepo, Xiuping Yu, et al.
Advanced Biology|May 9, 2022
The µ-Opioid Receptor in Cancer and Its Role in Perineural Invasion: A Short Review and New EvidenceJuan P Cata, Megan L Uhelski, Aysegul Gorur, et al.
Iscience|September 9, 2020
Generation of Phenothiazine with Potent Anti-TLK1 Activity for Prostate Cancer TherapyVibha Singh, Siddhant Bhoir, Rupesh V Chikhale, et al.
Organic & Biomolecular Chemistry|February 14, 2023
Synthesis, kinetics and cellular studies of new phenothiazine analogs as potent human-TLK inhibitorsDelna Johnson, Javeena Hussain, Siddhant Bhoir, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
International Journal of Molecular Sciences|July 14, 2023
Targeting Prostate Cancer, the 'Tousled Way'Siddhant Bhoir, Arrigo De Benedetti
Cancers|January 11, 2025
Beyond the Horizon: Rethinking Prostate Cancer Treatment Through Innovation and Alternative StrategiesSiddhant Bhoir, Arrigo De Benedetti
Scientific Reports|March 21, 2018
High yield bacterial expression, purification and characterisation of bioactive Human Tousled-like Kinase 1B involved in cancerSiddhant Bhoir, Althaf Shaik, Vijay Thiruvenkatam, et al.
Advanced Biology|May 3, 2023
The Role of Opioid Receptors in CancerSiddhant Bhoir, Megan Uhelski, Juan Jose Guerra-Londono, et al.
Biomedicines|November 25, 2023
Exploiting TLK1 and Cisplatin Synergy for Synthetic Lethality in Androgen-Insensitive Prostate CancerSiddhant Bhoir, Oluwatobi Ogundepo, Xiuping Yu, et al.
Advanced Biology|May 9, 2022
The µ-Opioid Receptor in Cancer and Its Role in Perineural Invasion: A Short Review and New EvidenceJuan P Cata, Megan L Uhelski, Aysegul Gorur, et al.
Iscience|September 9, 2020
Generation of Phenothiazine with Potent Anti-TLK1 Activity for Prostate Cancer TherapyVibha Singh, Siddhant Bhoir, Rupesh V Chikhale, et al.
Organic & Biomolecular Chemistry|February 14, 2023
Synthesis, kinetics and cellular studies of new phenothiazine analogs as potent human-TLK inhibitorsDelna Johnson, Javeena Hussain, Siddhant Bhoir, et al.
Pageof 1